He discusses his research in virology and how his team is working to produce better vaccines through understanding the immunology of helper T cells, germinal centers, and the human-naïve B-cell...
In this podcast, Infectious Diseases Consultant Advisory Board Member Daniel Eiras, MD, discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has...
In this podcast, Infectious Diseases Consultant Advisory Board Member Daniel Eiras, MD, discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has...
In this podcast, Bill Kapogiannis, MD, discusses the multi-Federal agency SMILE Collaborative (Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of HIV-infected youth),...
In this podcast, Linda Beer, PhD, from the Centers for Disease Control and Prevention, talks about her team's latest analysis of US surveillance data of adults with HIV infection that examined the...
In this podcast, Anthony Fauci, MD, from the NIAID, discusses comorbidities in people with HIV and how managing those comorbidities may be hindering progress toward ending the HIV epidemic.
In this podcast, Ralph Baric, PhD, from the University of North Carolina at Chapel Hill, discusses his latest research on the National Institute of Health's dengue vaccine, what the findings mean for...
He talks about the recent advancements in the distribution of cells in human tissues that primarily mediate the abnormalities in cystic fibrosis, how these advancements have influenced treatment...
